Not finding it? Sign in to also search OpenAlex live.
-
Mosaic HIV-1 vaccine regimen in southern African women (Imbokodo/HVTN 705/HPX2008): a randomised, double-blind, placebo-controlled, phase 2b trial2024 The Lancet Infectious Diseases article Immunology and Microbiology HIV Research and Treatment Open access
Glenda Gray, Kathryn Therese Mngadi, Ludo Lavreys, Steven Nijs, Peter B. Gilbert, John Hural, +58 more
46citations -
Impact of age and comorbidities on the efficacy and tolerability of bosutinib in previously treated patients with chronic myeloid leukemia: results from the phase 4 BYOND study
Gianantonio Rosti, Tim H. Brümmendorf, Bjørn Tore Gjertsen, Pilar Giraldo-Castellano, Fausto Castagnetti, Carlo B Gambacorti-Passerini, +6 more
10citations -
Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Antitumor Activity of the Cyclin-Dependent Kinase-9 (CDK9) Inhibitor AZD4573 in Relapsed/Refractory Hematological Malignancies: A Phase 1 First-in-Human Study
Tim H. Brümmendorf, Patrick G. Medd, Raphael Koch, Stephan Stilgenbauer, Shringi Sharma, Yun He, +4 more
8citations -
Sustained Improvement in Health-Related Quality of Life in Transplant-Ineligible Patients with Newly Diagnosed Multiple Myeloma Treated with Daratumumab, Lenalidomide, and Dexamethasone Versus Lenalidomide and Dexamethasone: Update of the Phase 3 MAIA Trial
Aurore Perrot, Thierry T.F. Facon, Shaji Kunnathu Kumar, Torben Plesner, Robert Zygmunt Orlowski, Philippe Moreau, +24 more
1citations -
Efficacy and Safety of Less Frequent/Lower Intensity Dosing of Talquetamab in Patients with Relapsed/Refractory Multiple Myeloma: Results from the Phase 1/2 MonumenTAL-1 Study
Ajai Chari, Albert Oriol, Amrita Y. Krishnan, Maria Del Carmen Martinez Chamorro, Luciano J. Costa, María‐Victoria Mateos, +9 more
50citations -
Rationale for and Design of Papilio-1: A Phase 1/2, Multicenter, Open-Label Study to Evaluate the Feasibility, Safety, and Efficacy of Point-of-Care-Manufactured Anti-B-Cell Maturation Antigen Chimeric Antigen Receptor T Cells (GLPG5301) in Relapsed/Refractory Multiple Myeloma
Niels W.C.J. van de Donk, Sébastien Anguille, Jo Caers, Marte C. Liefaard, Christian J. Jacques, Anna D.D. van Muyden
1citations -
Safety and immunogenicity of a two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Europe (EBOVAC2): a randomised, observer-blind, participant-blind, placebo-controlled, phase 2 trial2020 The Lancet Infectious Diseases article Medicine Viral Infections and Outbreaks Research Open access cited by 7 patents
Andrew John Pollard, Odile Launay, Jean‐Daniel Lelièvre, Christine Lacabaratz, Sophie Grande, Neil H. Goldstein, +84 more
173citations -
CROCuS, a Phase II Study Evaluating the Antiviral Activity, Clinical Outcomes, and Safety of Rilematovir in Children Aged ≥ 28 Days and ≤ 3 Years with Acute Respiratory Tract Infection Due to Respiratory Syncytial Virus
Fernando Ferrero, Chien‐Yu Lin, Johannes G. Liese, Kléber Giovanni Luz, T. Stoeva, Ágnes Németh, +14 more
15citations -
Imatinib alternating with regorafenib compared to imatinib alone for the first-line treatment of advanced gastrointestinal stromal tumor: The AGITG ALT-GIST intergroup randomized phase II trial2025 British Journal of Cancer article Medicine Gastrointestinal Tumor Research and Treatment Open access
Desmond Yip, John Raymond Zalcberg, Jean‐Yves Blay, David Espinoza, Timothy Jay Price, Sandrine I. Marreaud, +8 more
4citations -
Ropeginterferon alfa-2b in essential thrombocythemia of all risk levels ineligible for standard cytoreduction: 12-month primary endpoint analysis from the ROP-ET phase 3 study2025 Blood conference-abstract Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment Open access
Jean‐Jacques Kiladjian, Alberto Álvarez‐Larrán, Konstanze Döhner
2citations -
Efficacy and safety of encorafenib (enco) plus binimetinib (bini) in patients with BRAF V600E-mutant (BRAFV600E) metastatic non-small cell lung cancer (NSCLC) from the phase 2 PHAROS study.
Gregory J. Riely, Egbert Frederik Smit, Myung‐Ju Ahn, Enriqueta Felip, Suresh S. Ramalingam, Anne S. Tsao, +12 more
1citations -
MO533: Safety of Roxadustat versus Erythropoiesis-Stimulating Agents for Treatment of Anemia in Patients With Chronic Kidney Disease Incident to or not Receiving Dialysis: Pooled Analysis of Four Phase 3 Studies2022 Nephrology Dialysis Transplantation article Medicine Erythropoietin and Anemia Treatment Open access
Jonathan Barratt, Frank Dellanna, José María Portolés, Gabriel J. Choukroun, Luca De Nicola, Nada B. Dimkovic
0citations -
Phase I/II Study of AXL-Specific Antibody–Drug Conjugate Enapotamab Vedotin in Patients with Advanced Solid Tumors2025 Cancer Research Communications article Medicine Lung Cancer Treatments and Mutations Open access cited by 1 patent
Kristoffer Staal Rohrberg, Juanita Suzanne Lopez, Mohammed M. Milhem, Christian U. Blank, Irene L. M. Reijers, Fiona C. Thistlethwaite, +34 more
5citations -
LB0001 EFFICACY AND SAFETY OF DEUCRAVACITINIB UP TO WEEK 16 FROM POETYK PsA-1: A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 3 STUDY IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS2025 Annals of the Rheumatic Diseases conference-abstract Medicine Spondyloarthritis Studies and Treatments Open access
Désirée M F M van der Heijde, Philip J. Mease, Carle F. Paul, F. Behrens, Laure Gossec, Yuichiro Kaneko, +15 more
4citations